Fig. 1From: TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinomaKaplan-Meier curves for patients (A, B) with KRAS mutation, (C, D) with KRAS G12D mutation in KRASmut cases and (E, F) with alterations of 2–3 pathways among TP53, cell cycle pathway and TGFβ pathway. DFS and OS were displayed as median [95% CI]. NA indicated not availableBack to article page